These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9166833)

  • 1. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study.
    Borowitz MJ; Shuster J; Carroll AJ; Nash M; Look AT; Camitta B; Mahoney D; Lauer SJ; Pullen DJ
    Blood; 1997 Jun; 89(11):3960-6. PubMed ID: 9166833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia.
    Nakamura A; Tsurusawa M; Kato A; Taga T; Hatae Y; Miyake M; Mimaya J; Onodera N; Watanabe A; Watanabe T; Kanegane H; Matsushita T; Iwai A; Hyakuna N; Gushi K; Kawakami T; Sekine I; Izichi O; Asami K; Kikuta A; Tanaka A; Fujimoto T;
    Leuk Lymphoma; 2001 Jul; 42(3):393-8. PubMed ID: 11699404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CD45 antigen expression in pediatric acute lymphoblastic leukemia.
    Balasubramanian P; Singh J; Verma D; Kumar R; Bakhshi S; Tanwar P; Singh AR; Chopra A
    Blood Cells Mol Dis; 2021 Jul; 89():102562. PubMed ID: 33756412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
    Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
    Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
    Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
    Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value.
    Solano-Genesta M; Tarín-Arzaga L; Velasco-Ruiz I; Lutz-Presno JA; González-Llano O; Mancías-Guerra C; Rodríguez-Romo L; Ruiz-Delgado GJ; Ruiz-Argüelles GJ; Jaime-Pérez JC; Gómez-Almaguer D
    Hematology; 2012 Mar; 17(2):66-70. PubMed ID: 22664043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
    Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
    Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. The Austrian Pediatric Oncology Group.
    Fink FM; Köller U; Mayer H; Haas OA; Grümayer-Panzer ER; Urban C; Dengg K; Mutz I; Tüchler H; Gatterer-Menz I
    Med Pediatr Oncol; 1993; 21(5):340-6. PubMed ID: 8492748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
    Ratei R; Sperling C; Karawajew L; Schott G; Schrappe M; Harbott J; Riehm H; Ludwig WD
    Ann Hematol; 1998 Sep; 77(3):107-14. PubMed ID: 9797079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
    Schultz KR; Pullen DJ; Sather HN; Shuster JJ; Devidas M; Borowitz MJ; Carroll AJ; Heerema NA; Rubnitz JE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Gaynon PS; Camitta BM
    Blood; 2007 Feb; 109(3):926-35. PubMed ID: 17003380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features.
    Behm FG; Raimondi SC; Schell MJ; Look AT; Rivera GK; Pui CH
    Blood; 1992 Feb; 79(4):1011-6. PubMed ID: 1531305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow Cytometric Evaluation of Double/Triple Hit Lymphoma.
    Roth CG; Gillespie-Twardy A; Marks S; Agha M; Raptis A; Hou JZ; Farah R; Lin Y; Qian Y; Pantanowitz L; Boyiadzis M
    Oncol Res; 2016; 23(3):137-46. PubMed ID: 26931436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
    Raponi S; De Propris MS; Intoppa S; Milani ML; Vitale A; Elia L; Perbellini O; Pizzolo G; Foá R; Guarini A
    Leuk Lymphoma; 2011 Jun; 52(6):1098-107. PubMed ID: 21348573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study.
    Pullen J; Shuster JJ; Link M; Borowitz M; Amylon M; Carroll AJ; Land V; Look AT; McIntyre B; Camitta B
    Leukemia; 1999 Nov; 13(11):1696-707. PubMed ID: 10557041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
    Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
    Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Uckun FM; Sather HN; Gaynon PS; Arthur DC; Trigg ME; Tubergen DG; Nachman J; Steinherz PG; Sensel MG; Reaman GH
    Blood; 1997 Jul; 90(1):28-35. PubMed ID: 9207434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.
    Trueworthy R; Shuster J; Look T; Crist W; Borowitz M; Carroll A; Frankel L; Harris M; Wagner H; Haggard M
    J Clin Oncol; 1992 Apr; 10(4):606-13. PubMed ID: 1548523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.